TrianglePUBLICATIONS · 17051246
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Leukemia
- Publication date
- 2007 Jan
- First author
- Taksin AL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Taksin AL
- type
- Author
- name
- Legrand O
- type
- Author
- name
- Raffoux E
- type
- Author
- name
- de Revel T
- type
- Author
- name
- Thomas X
- type
- Author
- name
- Contentin N
- type
- Author
- name
- Bouabdallah R
- type
- Author
- name
- Pautas C
- type
- Author
- name
- Turlure P
- type
- Author
- name
- Reman O
- type
- Author
- name
- Gardin C
- type
- Author
- name
- Varet B
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Taksin AL
- type
- Author
- name
- Legrand O
- type
- Author
- name
- Raffoux E
- type
- Author
- name
- de Revel T
- type
- Author
- name
- Thomas X
- type
- Author
- name
- Contentin N
- type
- Author
- name
- Bouabdallah R
- type
- Author
- name
- Pautas C
- type
- Author
- name
- Turlure P
- type
- Author
- name
- Reman O
- type
- Author
- name
- Gardin C
- type
- Author
- name
- Varet B
- type
- Author
- bibliography ids
- nci-bib-a1c8afe462c6264954c9116c
- book metadata
- content sha256
- 2a3977866033fa00fb363df044f84d3a07592e6ae526bc49fde463bad3f718f8
- document type
- citation
- dois
- 10.1038/sj.leu.2404434
- electronic publication date
- display
- 2006 Oct 19
- precision
- day
- year
- 2006
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17051246
- immutable id
- pubmed:17051246@2a3977866033fa00fb363df044f84d3a07592e6ae526bc49fde463bad3f718f8
- journal
- abbreviation
- Leukemia
- issn electronic
- Source null
- issn print
- 0887-6924
- issue
- 1
- name
- Leukemia
- nlm unique id
- 8704895
- pages
- 66-71
- volume
- 21
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 17051246
- provenance
- batch id
- 2c499a3b9f4867a74c49
- provider
- NCBI PubMed ESummary
- record sha256
- e5fe037d45fe26a8714b897013cc4d1f8f77cd3150078707f069f61363e97851
- response sha256
- 3b299651c5c5270455877b65b6e5acff71ad5f85103b7f9582efe63c52588326
- retrieved at
- 2026-09-09T23:46:08.887541+00:00
- publication date
- display
- 2007 Jan
- precision
- month
- year
- 2007
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.
Preserved source evidence · Not medical advice